Impact of relative dose intensity on bone marrow suppression induced by S-1: retrospective observational study.

Toshinori HiraiRyuichi OgawaRyosuke YamagaToshimasa Itoh

Published in: Journal of pharmaceutical health care and sciences (2018)

Reduced dose of S-1 still has the risk of developing bone marrow suppression. Clinicians should assess RDI to identify high risk patients with bone marrow suppression induced by S-1.

Keyphrases

bone marrow
mesenchymal stem cells
palliative care
high intensity